TreeHouse Foods, Inc.
TreeHouse Foods, Inc. (THS) Financial Performance & Income Statement Overview
Explore the financials of TreeHouse Foods, Inc. (THS), including yearly and quarterly data on income, cash flow, and balance sheets.
TreeHouse Foods, Inc. (THS) Income Statement & Financial Overview
Explore comprehensive income reports for TreeHouse Foods, Inc. THS, broken down by year and quarter.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $798.00M | $792.00M | $905.70M | $839.10M |
Cost of Revenue | $658.80M | $676.80M | $728.80M | $707.90M |
Gross Profit | $139.20M | $115.20M | $176.90M | $131.20M |
Gross Profit Ratio | $0.17 | $0.15 | $0.20 | $0.16 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $86.30M | $92.10M | $78.70M | $82.00M |
Operating Expenses | $111.90M | $120.70M | $96.40M | $99.40M |
Total Costs & Expenses | $770.70M | $797.50M | $825.20M | $807.30M |
Interest Income | -$200000.00 | $2.80M | $0.00 | $100000.00 |
Interest Expense | $22.20M | $19.30M | $16.20M | $16.00M |
Depreciation & Amortization | $0.00 | $41.40M | $37.60M | $36.70M |
EBITDA | $27.30M | $17.10M | $127.40M | $48.40M |
EBITDA Ratio | $0.03 | $0.02 | $0.14 | $0.06 |
Operating Income | $27.30M | -$5.50M | $80.50M | $31.80M |
Operating Income Ratio | $0.03 | -$0.007 | $0.09 | $0.04 |
Other Income/Expenses (Net) | -$32.90M | -$38.10M | -$6.90M | -$36.10M |
Income Before Tax | -$5.60M | -$43.60M | $73.60M | -$4.30M |
Income Before Tax Ratio | -$0.007 | -$0.06 | $0.08 | -$0.005 |
Income Tax Expense | -$2.70M | -$11.80M | $14.90M | -$900000.00 |
Net Income | -$2.90M | -$31.80M | $58.70M | -$3.40M |
Net Income Ratio | -$0.004 | -$0.04 | $0.06 | -$0.004 |
EPS | -$0.06 | -$0.63 | $1.16 | -$0.07 |
Diluted EPS | -$0.06 | -$0.63 | $1.15 | -$0.07 |
Weighted Avg Shares Outstanding | $50.50M | $50.30M | $50.80M | $51.90M |
Weighted Avg Shares Outstanding (Diluted) | $50.50M | $50.30M | $51.20M | $51.90M |
Over the past four quarters, TreeHouse Foods, Inc. demonstrated steady revenue growth, increasing from $839.10M in Q3 2024 to $798.00M in Q2 2025. Operating income reached $27.30M in Q2 2025, maintaining a consistent 3% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $27.30M, reflecting operational efficiency. Net income rose to -$2.90M, with EPS at -$0.06. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan